
Hidehito Horinouchi/X
Apr 7, 2025, 16:05
Systematic review and meta-analysis of molecular tumor board data on clinical effectiveness and evaluation gaps
Hidehito Horinouchi, Assistant Chief at National Cancer Center Hospital, shared on X about a recent paper by Beryl Primrose Gladstone.
“Systematic review and meta-analysis of molecular tumor board data on clinical effectiveness and evaluation gaps.
MTB improves outcomes of pts, but standardization is needed”
Systematic review and meta-analysis of molecular tumor board data on clinical effectiveness and evaluation gaps
Authors: Beryl Primrose Gladstone, Janina Beha, Arisa Hakariya, Pavlos Missios, Nisar P. Malek and Michael Bitzer.
More posts featuring Hidehito Horinouchi.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 7, 2025, 17:40
Apr 7, 2025, 17:31
Apr 7, 2025, 17:31
Apr 7, 2025, 17:19
Apr 7, 2025, 17:03
Apr 7, 2025, 16:51